DIGESTIVES
DATE: 19-11-2026
TIME: 09:00 / 10:30
DURATION: 1 hour and 30 minutos
LOCATION: Plenary Room
ctDNA AND MINIMAL RESIDUAL DISEASE: ARE WE READY TO CHANGE THERAPEUTIC DECISIONS?
NEW THERAPEUTIC TARGETS IN ESOPHAGOGASTRIC AND PANCREATIC CANCER: HER2, CLDN18.2, FGFR2B, RAS AND BEYOND
HAS THE FUTURE ALREADY ARRIVED? ANTIBODY–DRUG CONJUGATES (ADCS) AND BISPECIFIC ANTIBODIES IN GASTROINTESTINAL ONCOLOGY